InvestorsHub Logo
Followers 14
Posts 733
Boards Moderated 0
Alias Born 12/09/2013

Re: willyw post# 2115

Wednesday, 12/15/2021 4:49:02 PM

Wednesday, December 15, 2021 4:49:02 PM

Post# of 3015
I'd like to think that this is a bottom.
I've been waiting and today I bought a bit more.
It appears that I wasn't alone.
Anyway, the day ended with a hammer on good volume.

Covid isn't going away.
ENTA will benefit by PFE's success with their PI. IMHO

Protease inhibitors as a therapeutic treatment for covid will soon be validated. People will see patient success, prescription numbers/$$$ and realize that theraputics will help recovery and transition from pandemic to endemic.

I understand people not wanting to buy until EDP-235 enters clinic, but that could be in the near future and Luly has mentioned phase 2/3 in 2022.
I would think a partner in covid would bolster share price dramatically. Would it be reasonable to compare it to the AVIR/Roche collaboration?

It's an aside- but Luly has mentioned a few times that EDP-235 shows potency against other coronaviruses.
At some point if successful that may also have some non-covid value attributed and some follow on compounds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News